獣医用皮膚科医薬品市場 - 世界の産業規模、シェア、動向、機会、予測：適応症別、動物タイプ別、流通チャネル別、投与経路別、地域別、競合、2018年～2028年

獣医用皮膚科医薬品の世界市場規模は2022年に148億2,000万米ドルとなり、2028年までのCAGRは5.25%で、予測期間中に目覚ましい成長を遂げると予測されています。

世界の獣医業界では近年、専門的な治療に対する需要が急増しています。こうした専門分野の中でも、獣医用皮膚科はペット医療に不可欠な要素として際立っています。皮膚疾患、アレルギー、その他の皮膚の問題は、動物個体群のかなりの部分に影響を及ぼしており、これが世界の獣医用皮膚科医薬品市場の成長を促しています。獣医用皮膚科は、動物の皮膚疾患の診断と治療を含みます。これらの疾患は、アレルギーや寄生虫のような一般的な問題から、自己免疫疾患や皮膚腫瘍のような深刻な問題まで多岐にわたります。世界の獣医用皮膚科医薬品市場は、主に犬や猫などのコンパニオンアニマルを対象としているが、同様に皮膚疾患に苦しむ可能性のある家畜にも及んでいます。

世界の獣医用皮膚科医薬品市場の大きな促進要因は、世界中でペットを飼う人が増えていることです。犬や猫などのペットを家に迎える人が増えるにつれ、皮膚科治療を含む医療サービスの需要が高まっています。ペットの飼い主は、動物が必要とする健康について知識を深めています。皮膚の健康の重要性をますます認識するようになり、ペットのために専門的なケアや治療を求める傾向が強くなっています。獣医業界では、診断や治療における技術の進歩が見られます。これには、レーザー治療、高度な診断、低侵襲手術の使用が含まれ、より精密で効果的な皮膚科治療が提供されています。牛、馬、豚のような動物の皮膚の問題は、大きな経済的損失につながる可能性があるため、畜産部門も獣医用皮膚科市場に貢献しています。農家や家畜の所有者は、動物の健康を維持するために効果的な皮膚科ソリューションを求めています。ペット保険の普及により、ペットの飼い主が全額自己負担することなく、皮膚科治療を含む専門的な獣医療を受けることが経済的に可能になりました。獣医用皮膚科医薬品メーカーは、幅広い皮膚疾患に対応する革新的な治療薬や医薬品を開発し、製品ラインアップを拡充し続けています。このような製品の多様性が市場の成長を促進しています。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の獣医用皮膚科医薬品市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 適応症別（寄生虫感染症、アレルギー性感染症、その他）
  • 動物タイプ別（コンパニオンアニマル、畜産動物）
  • 流通チャネル別（病院薬局、小売、eコマース）
  • 投与経路別（局所、注射、経口）
  • 地域別
  • 企業別（2022年）
• 市場マップ
  • 適応症別
  • 動物タイプ別
  • 流通チャネル別
  • 投与経路別
  • 地域別

第5章 アジア太平洋地域の獣医用皮膚科医薬品市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 適応症別
  • 動物タイプ別
  • 流通チャネル別
  • 投与経路別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の獣医用皮膚科医薬品市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 適応症別
  • 動物タイプ別
  • 流通チャネル別
  • 投与経路別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の獣医用皮膚科医薬品市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 適応症別
  • 動物タイプ別
  • 流通チャネル別
  • 投与経路別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の獣医用皮膚科医薬品市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 適応症別
  • 動物タイプ別
  • 流通チャネル別
  • 投与経路別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの獣医用皮膚科医薬品市場展望

• 市場規模および予測
  • 金額別
• 市場シェアと予測
  • 適応症別
  • 動物タイプ別
  • 流通チャネル別
  • 投与経路別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

第12章 世界の獣医用皮膚科医薬品市場：SWOT分析

第13章 ポーターのファイブフォース分析

第14章 競合情勢

• Elanco Animal Health Incorporated
• Ceva Sante Animale
• Vetoquinol
• Merck & Co., Inc.
• Zoetis Inc.
• Virbac
• Bimeda, Inc
• Vivaldis
• Bioiberica S.A.U.
• Boehringer Ingelheim International GmbH

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Veterinary Dermatology Drugs Market was valued at USD 14.82 Billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.25% through 2028. The global veterinary industry has witnessed a surge in demand for specialized treatments in recent years. Among these specialized fields, veterinary dermatology stands out as an essential component of pet healthcare. Skin disorders, allergies, and other dermatological issues affect a significant portion of the animal population, prompting the growth of the global veterinary dermatology drugs market. Veterinary dermatology involves the diagnosis and treatment of skin conditions in animals. These conditions can range from common problems like allergies and parasites to more severe issues like autoimmune diseases and skin tumors. The global veterinary dermatology drugs market primarily caters to companion animals such as dogs and cats but also extends to livestock, which can suffer from skin disorders as well.

A significant driver of the global veterinary dermatology drugs market is the increasing number of pet owners across the world. As more people welcome dogs, cats, and other pets into their homes, the demand for healthcare services, including dermatological treatments, has grown. Pet owners are becoming more informed about their animals' health needs. They are increasingly aware of the significance of dermatological health and are more likely to seek specialized care and treatment for their pets. The veterinary industry has seen technological advancements in diagnostics and treatments. This includes the use of laser therapy, advanced diagnostics, and minimally invasive procedures, which provide more precise and effective dermatological treatments. The livestock sector also contributes to the veterinary dermatology market, as skin issues in animals like cows, horses, and pigs can lead to significant economic losses. Farmers and livestock owners are seeking effective dermatological solutions to maintain the health of their animals. The rise in pet insurance adoption has made it more financially feasible for pet owners to seek specialized veterinary care, including dermatology treatments, without bearing the full cost themselves. Veterinary dermatology drug manufacturers are continually expanding their product range, developing innovative treatments and medications to address a wide range of skin conditions. This diversity in offerings is driving market growth.

Key Market Drivers

Rising Pet Ownership is Driving the Global Veterinary Dermatology Drugs Market

In recent years, pet ownership has experienced an exponential surge worldwide, and with it, the demand for specialized veterinary care. One particular area that has seen significant growth is veterinary dermatology, as more pet owners are becoming aware of the importance of their pets' skin and coat health. As pets are increasingly considered as beloved members of the family, the global veterinary dermatology drugs market is thriving. The bond between humans and their pets has never been stronger. The COVID-19 pandemic led to a significant increase in pet adoption and ownership, as many people sought companionship and comfort during lockdowns. This surge in pet adoption has continued to grow, transcending geographical boundaries. Furthermore, urbanization and changing lifestyles have made pet ownership more accessible and desirable for people of all ages and backgrounds. As pet ownership grows, so does the awareness of the importance of pet healthcare. This awareness extends to dermatological issues, which are among the most common health concerns for pets. Conditions like allergies, infections, parasites, and other skin-related problems can significantly affect a pet's well-being, leading to discomfort, pain, and reduced quality of life.

Veterinary dermatology is a specialized branch of veterinary medicine dedicated to diagnosing, treating, and preventing skin, hair, and nail disorders in animals. Dermatological problems in pets are often overlooked or misdiagnosed, leading to prolonged suffering for the animals and frustration for their owners. A pet's skin and coat play a vital role in maintaining their overall health. A healthy skin barrier protects against infections, regulates body temperature, and plays a crucial role in sensory perception. Dermatological issues can manifest as itching, hair loss, rashes, or even more severe complications if left untreated. This emphasizes the need for proper veterinary care, which has spurred the growth of the veterinary dermatology drugs market.

As pet owners become more informed about dermatological problems in their pets, they are more likely to seek professional advice and treatment. This growing awareness drives demand for dermatological drugs and treatments. Technological advancements in veterinary medicine have resulted in better diagnostic tools and treatment options for dermatological conditions. This has improved the overall quality of care and made pet owners more willing to invest in treatment. With pets becoming integral members of the family, pet owners are willing to go to great lengths to ensure their pets' comfort and well-being. This extends to investing in specialized treatments and medications for dermatological issues. The growth in the pet insurance industry has made it more affordable for pet owners to seek veterinary care, including dermatological treatments, without breaking the bank.

Increasing Incidence of Dermatological Conditions is Driving the Global Veterinary Dermatology Drugs Market

The global veterinary dermatology drugs market is experiencing a notable surge in growth as the incidence of dermatological conditions in pets and animals continues to rise. Pet owners around the world are increasingly recognizing the importance of maintaining the skin and coat health of their beloved companions. This heightened awareness, coupled with advancements in veterinary dermatology treatments, is driving the expansion of the global market for veterinary dermatology drugs. Skin-related issues, such as allergies, infections, and parasites, are common among pets and animals. Dermatological conditions can cause discomfort, distress, and, in severe cases, impact an animal's overall quality of life. This has led to a surge in pet owners seeking veterinary advice and treatments for their animals' skin and coat problems.

The field of veterinary dermatology has seen remarkable advancements over the years. These breakthroughs have not only improved the diagnosis and treatment of dermatological conditions but have also expanded the range of available treatment options. Modern diagnostic tools, including skin cytology, biopsies, and advanced imaging techniques, have improved the accuracy of diagnosing dermatological conditions. This allows veterinarians to provide more targeted and effective treatments. The introduction of innovative drugs and therapies for dermatological conditions has been a significant driver of market growth. Medications, topical creams, shampoos, and immunotherapy options have all seen substantial improvements in recent years. Allergies are a leading cause of dermatological conditions in pets. New treatments, including allergen-specific immunotherapy, have improved the management of allergies in animals. Veterinary dermatology has evolved into a specialized field with more veterinarians focusing on skin and coat issues. Specialized knowledge has resulted in more effective treatments and care.

The global veterinary dermatology drugs market is expanding rapidly due to the increased incidence of dermatological conditions and the willingness of pet owners to seek proper care for their animals. The market is not limited to pharmaceuticals but also encompasses a wide range of products, including shampoos, creams, and dietary supplements designed to improve skin and coat health. Pet owners are becoming increasingly educated about dermatological issues in animals, prompting them to seek veterinary care and treatment options. The availability of cutting-edge diagnostic tools and treatment options is driving market growth, as veterinarians can provide better care for their patients. Companies in the veterinary dermatology sector continue to invest in research and development, leading to innovative treatments and products that cater to the specific needs of different animals. The growth of veterinary clinics, dermatology centres, and specialty hospitals is making it easier for pet owners to access specialized care for their pets.

Key Market Challenges

Regulatory Hurdles

One of the primary challenges in the veterinary dermatology drugs market is the complex and evolving regulatory landscape. Different countries have varying regulations for approving and marketing these drugs, making it challenging for manufacturers to navigate the global market effectively. The need to comply with multiple regulatory bodies can be time-consuming and costly, hampering the development and distribution of these drugs.

Limited Research and Development

Compared to the pharmaceutical industry for humans, the veterinary dermatology drugs sector receives considerably less attention from the research and development (R&D) community. A shortage of investments and resources for developing innovative treatments for animal skin conditions results in limited treatment options. This scarcity hinders the market's potential for growth.

High Development Costs

Developing new veterinary dermatology drugs can be expensive and time-consuming. Companies must invest in extensive research, clinical trials, and regulatory approval processes. These high development costs can make it financially challenging for smaller companies to enter the market and lead to higher prices for consumers.

Competition and Pricing Pressure

The global veterinary dermatology drugs market is highly competitive, with a limited number of large pharmaceutical companies dominating the industry. This competition exerts pricing pressure, often leading to reduced profit margins. While this may be beneficial for consumers, it discourages innovation and can stifle smaller businesses.

Antibiotic Resistance

Antibiotic resistance is a growing concern in both human and veterinary medicine. The overuse and misuse of antibiotics in animals can lead to the development of antibiotic-resistant strains of bacteria. This resistance can render existing treatments ineffective, and the market's challenge is to develop alternative therapies that are both effective and sustainable.

Seasonal Variability

The demand for veterinary dermatology drugs can be influenced by seasonal factors. Allergies, for example, may worsen during specific times of the year, resulting in fluctuating sales. This seasonality poses a challenge for companies in terms of production planning and inventory management.

Pet Owner Compliance

Another challenge faced by the veterinary dermatology drugs market is pet owner compliance. Many treatments require careful administration and regular application, which can be difficult for pet owners to maintain. Poor compliance can reduce the effectiveness of treatments, impacting the market's growth.

Diagnosis and Treatment Complexity

The diagnosis and treatment of dermatological issues in animals can be complex. Identifying the root cause of skin problems often involves multiple tests and sometimes trial-and-error approaches. This complexity can frustrate pet owners and result in longer treatment periods, leading to challenges in the market.

Key Market Trends

Technological Advancements

The global veterinary dermatology drugs market is experiencing significant growth, driven by a combination of factors, with technological advancements taking center stage. As pet ownership continues to rise, so does the demand for specialized veterinary care, including the treatment of dermatological issues. Veterinary dermatology drugs play a pivotal role in addressing skin and coat-related conditions in pets. With the development of cutting-edge technologies and innovative treatment methods, this market is expanding rapidly. One of the key drivers of the veterinary dermatology drugs market is the adoption of advanced diagnostic technologies. Veterinarians now have access to state-of-the-art tools for identifying skin conditions and allergies in animals. Techniques such as digital dermatoscopy, patch testing, and allergen specific IgE testing are becoming commonplace in veterinary dermatology. These technologies allow for accurate and quicker diagnosis, leading to more effective treatment.

In parallel with diagnostic advancements, the pharmaceutical industry is also making remarkable strides in the development of veterinary dermatology drugs. New medications and therapies are being introduced to the market, offering safer and more effective treatment options for pets suffering from dermatological conditions. One significant development is the use of monoclonal antibodies in veterinary dermatology. These targeted therapies can provide relief from allergies, pruritus, and other skin conditions in pets. Additionally, pharmaceutical companies are investing in research to develop more user-friendly and patient-compliant forms of medication, such as oral tablets and sprays. This not only makes treatment easier for pet owners but also increases treatment adherence.

Advancements in technology have allowed veterinarians to provide more personalized treatment plans for their patients. With the help of data analytics and artificial intelligence, they can analyze a pet's medical history, genetics, and environmental factors to develop a treatment plan tailored to the individual's needs. This customized approach to treatment enhances the effectiveness of veterinary dermatology drugs and minimizes the risk of side effects. The rapid growth of telemedicine in the veterinary industry is also contributing to the expansion of the veterinary dermatology drugs market. Pet owners can now access remote consultations with board-certified veterinary dermatologists, providing convenient access to expert advice and diagnoses. This not only saves time but also helps in early diagnosis and treatment of skin conditions in pets. Telemedicine complements traditional in-person veterinary visits and ensures that dermatological issues are addressed promptly. The demand for veterinary dermatology drugs is not limited to any specific region. As pet ownership becomes more widespread across the globe, the market for these specialized drugs is expanding internationally. Emerging markets are experiencing significant growth in this sector, offering new opportunities for pharmaceutical companies and technology providers.

Segmental Insights

Indication Insights

Based on the category of Indication, Parasitic Infections emerged as the dominant player in the global market for Veterinary Dermatology Drugs in 2022. Parasitic infections in animals, especially in companion animals like dogs and cats, are becoming increasingly prevalent. These infections can range from common flea infestations to more severe conditions like sarcoptic mange and ear mites. The rise in these infections can be attributed to various factors, including climate change, increased pet travel, and changes in pet ownership habits. Changing weather patterns and global warming have expanded the geographic ranges of parasites, leading to an increased risk of infections in previously unaffected areas. As people travel more with their pets, they expose their animals to different environments and potentially to new parasites. This increases the risk of parasitic infections. The growing humanization of pets and the trend toward urban living have brought pets into closer contact with potential sources of parasitic infections, such as other animals and environments.

Animal Type Insights

The Companion animals segment is projected to experience rapid growth during the forecast period. Companion animals, or pets, have always held a special place in the hearts and homes of people around the world. The 21st century has seen a significant surge in pet ownership. In many countries, the number of households with pets now exceeds those without. This trend can be attributed to various factors, including changing lifestyles, a greater focus on emotional well-being, and the therapeutic benefits of owning pets. With the growing trend of pet ownership, there is a heightened awareness among pet owners regarding the overall health and well-being of their furry friends. In particular, dermatological issues in pets are becoming increasingly recognized. Skin conditions, allergies, and other dermatological problems in dogs and cats can have a significant impact on their quality of life. As a result, pet owners are increasingly seeking professional veterinary care and specialized dermatology drugs to address these issues effectively.

Regional Insights

North America emerged as the dominant player in the global Veterinary Dermatology Drugs market in 2022, holding the largest market share in terms of value. North America boasts a highly developed veterinary healthcare system, with skilled professionals, cutting-edge technologies, and a strong commitment to animal welfare. This environment encourages pet owners to seek dermatological treatment for their beloved animals, thus boosting the market for veterinary dermatology drugs. The United States and Canada have some of the highest pet ownership rates in the world. The sheer number of pets in these countries creates a massive consumer base for veterinary dermatology drugs, making North America an attractive market for manufacturers.

Key Market Players

Elanco Animal Health Incorporated

Ceva Sante Animale

Vetoquinol

Merck & Co., Inc.

Zoetis Inc.

Virbac

Bimeda, Inc

Vivaldis

Bioiberica S.A.U.

Boehringer Ingelheim International GmbH

Report Scope:

In this report, the Global Veterinary Dermatology Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Dermatology Drugs Market, By Indication:

• Parasitic Infections
• Allergic Infections
• Others

Veterinary Dermatology Drugs Market, By Animal Type:

• Companion Animals
• Livestock Animals

Veterinary Dermatology Drugs Market, By Distribution Channel:

• Hospital Pharmacies
• Retail
• E-commerce

Veterinary Dermatology Drugs Market, By Route of Administration:

• Tropical
• Injectable
• Oral

Veterinary Dermatology Drugs Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Veterinary Dermatology Drugs Market.

Available Customizations:

• Global Veterinary Dermatology Drugs market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Veterinary Dermatology Drugs Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Indication (Parasitic Infections, Allergic Infections, Others)
  • 4.2.2. By Animal Type (Companion Animals, Livestock Animals)
  • 4.2.3. By Distribution Channel (Hospital Pharmacies, Retail, E-commerce)
  • 4.2.4. By Route of Administration (Tropical, Injectable, Oral)
  • 4.2.5. By Region
  • 4.2.6. By Company (2022)
• 4.3. Market Map
  • 4.3.1. By Indication
  • 4.3.2. By Animal Type
  • 4.3.3. By Distribution Channel
  • 4.3.4. By Route of Administration
  • 4.3.5. By Region

5. Asia Pacific Veterinary Dermatology Drugs Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Indication
  • 5.2.2. By Animal Type
  • 5.2.3. By Distribution Channel
  • 5.2.4. By Route of Administration
  • 5.2.5. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Veterinary Dermatology Drugs Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Indication
      • 5.3.1.2.2. By Animal Type
      • 5.3.1.2.3. By Distribution Channel
      • 5.3.1.2.4. By Route of Administration
  • 5.3.2. India Veterinary Dermatology Drugs Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Indication
      • 5.3.2.2.2. By Animal Type
      • 5.3.2.2.3. By Distribution Channel
      • 5.3.2.2.4. By Route of Administration
  • 5.3.3. Australia Veterinary Dermatology Drugs Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Indication
      • 5.3.3.2.2. By Animal Type
      • 5.3.3.2.3. By Distribution Channel
      • 5.3.3.2.4. By Route of Administration
  • 5.3.4. Japan Veterinary Dermatology Drugs Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Indication
      • 5.3.4.2.2. By Animal Type
      • 5.3.4.2.3. By Distribution Channel
      • 5.3.4.2.4. By Route of Administration
  • 5.3.5. South Korea Veterinary Dermatology Drugs Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Indication
      • 5.3.5.2.2. By Animal Type
      • 5.3.5.2.3. By Distribution Channel
      • 5.3.5.2.4. By Route of Administration

6. Europe Veterinary Dermatology Drugs Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Indication
  • 6.2.2. By Animal Type
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Route of Administration
  • 6.2.5. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Veterinary Dermatology Drugs Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Indication
      • 6.3.1.2.2. By Animal Type
      • 6.3.1.2.3. By Distribution Channel
      • 6.3.1.2.4. By Route of Administration
  • 6.3.2. Germany Veterinary Dermatology Drugs Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Indication
      • 6.3.2.2.2. By Animal Type
      • 6.3.2.2.3. By Distribution Channel
      • 6.3.2.2.4. By Route of Administration
  • 6.3.3. Spain Veterinary Dermatology Drugs Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Indication
      • 6.3.3.2.2. By Animal Type
      • 6.3.3.2.3. By Distribution Channel
      • 6.3.3.2.4. By Route of Administration
  • 6.3.4. Italy Veterinary Dermatology Drugs Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Indication
      • 6.3.4.2.2. By Animal Type
      • 6.3.4.2.3. By Distribution Channel
      • 6.3.4.2.4. By Route of Administration
  • 6.3.5. United Kingdom Veterinary Dermatology Drugs Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Indication
      • 6.3.5.2.2. By Animal Type
      • 6.3.5.2.3. By Distribution Channel
      • 6.3.5.2.4. By Route of Administration

7. North America Veterinary Dermatology Drugs Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Indication
  • 7.2.2. By Animal Type
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Route of Administration
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Veterinary Dermatology Drugs Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Indication
      • 7.3.1.2.2. By Animal Type
      • 7.3.1.2.3. By Distribution Channel
      • 7.3.1.2.4. By Route of Administration
  • 7.3.2. Mexico Veterinary Dermatology Drugs Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Indication
      • 7.3.2.2.2. By Animal Type
      • 7.3.2.2.3. By Distribution Channel
      • 7.3.2.2.4. By Route of Administration
  • 7.3.3. Canada Veterinary Dermatology Drugs Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Indication
      • 7.3.3.2.2. By Animal Type
      • 7.3.3.2.3. By Distribution Channel
      • 7.3.3.2.4. By Route of Administration

8. South America Veterinary Dermatology Drugs Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Indication
  • 8.2.2. By Animal Type
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Route of Administration
  • 8.2.5. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Veterinary Dermatology Drugs Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Indication
      • 8.3.1.2.2. By Animal Type
      • 8.3.1.2.3. By Distribution Channel
      • 8.3.1.2.4. By Route of Administration
  • 8.3.2. Argentina Veterinary Dermatology Drugs Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Indication
      • 8.3.2.2.2. By Animal Type
      • 8.3.2.2.3. By Distribution Channel
      • 8.3.2.2.4. By Route of Administration
  • 8.3.3. Colombia Veterinary Dermatology Drugs Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Indication
      • 8.3.3.2.2. By Animal Type
      • 8.3.3.2.3. By Distribution Channel
      • 8.3.3.2.4. By Route of Administration

9. Middle East and Africa Veterinary Dermatology Drugs Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Indication
  • 9.2.2. By Animal Type
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Route of Administration
  • 9.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Veterinary Dermatology Drugs Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Indication
      • 9.3.1.2.2. By Animal Type
      • 9.3.1.2.3. By Distribution Channel
      • 9.3.1.2.4. By Route of Administration
  • 9.3.2. Saudi Arabia Veterinary Dermatology Drugs Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Indication
      • 9.3.2.2.2. By Animal Type
      • 9.3.2.2.3. By Distribution Channel
      • 9.3.2.2.4. By Route of Administration
  • 9.3.3. UAE Veterinary Dermatology Drugs Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Indication
      • 9.3.3.2.2. By Animal Type
      • 9.3.3.2.3. By Distribution Channel
      • 9.3.3.2.4. By Route of Administration

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Veterinary Dermatology Drugs Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Elanco Animal Health Incorporated
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Product & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Ceva Sante Animale
• 14.3. Vetoquinol
• 14.4. Merck & Co., Inc.
• 14.5. Zoetis Inc.
• 14.6. Virbac
• 14.7. Bimeda, Inc
• 14.8. Vivaldis
• 14.9. Bioiberica S.A.U.
• 14.10. Boehringer Ingelheim International GmbH

15. Strategic Recommendations

16. About Us & Disclaimer